Address	2155 Park Boulevard Palo Alto California 94306 United States
Employees	-
Website	http://www.eigerbio.com
Updated	07/08/2019
Eiger BioPharmaceuticals, Inc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for orphan diseases. It focuses on product candidates for the treatment of orphan diseases such as Sarasar, Pegylated Interferon Lambda, Exendin 9-39, and Ubenimex. The company was founded by David A.